We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$11.2B
AUM Growth
+$921M
Cap. Flow
+$201M
Cap. Flow %
1.79%
Top 10 Hldgs %
19.59%
Holding
393
New
24
Increased
178
Reduced
115
Closed
8

Top Sells

Rank Stock Value
1
CMD
Cantel Medical Corporation
CMD
+$52.2M
2
BRKR icon
Bruker
BRKR
+$42.9M
3
WSM icon
Williams-Sonoma
WSM
+$40.5M
4
MMM icon
3M
MMM
+$34.1M
5
SBNY
Signature Bank
SBNY
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 19.74%
2 Financials 16.42%
3 Healthcare 14.76%
4 Industrials 14.05%
5 Consumer Discretionary 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDB icon
151
Independent Bank
INDB
$4.1B
$26.2M 0.23%
347,420
+96,268
+38% +$7.74M
AYI icon
152
Acuity Brands
AYI
$10.3B
$26.2M 0.23%
139,927
-4,265
-3% -$775K
BRO icon
153
Brown & Brown
BRO
$25B
$26.2M 0.23%
492,103
+31,677
+7% +$1.63M
BRK.B icon
154
Berkshire Hathaway Class B
BRK.B
$1.11T
$25.2M 0.22%
90,761
-41,004
-31% -$11.5M
CATY icon
155
Cathay General Bancorp
CATY
$4.25B
$25.2M 0.22%
640,241
-24,000
-4% -$988K
AFG icon
156
American Financial Group
AFG
$12B
$25.1M 0.22%
201,333
+18,032
+10% +$2.25M
DOX icon
157
Amdocs
DOX
$5.83B
$25.1M 0.22%
324,156
+19,847
+7% +$1.53M
SCI icon
158
Service Corp International
SCI
$11.7B
$24.8M 0.22%
462,274
+46,653
+11% +$2.48M
XOM icon
159
ExxonMobil
XOM
$634B
$24.5M 0.22%
388,337
+7,487
+2% +$447K
CL icon
160
Colgate-Palmolive
CL
$74.2B
$24.3M 0.22%
298,237
+13,595
+5% +$1.11M
CPK icon
161
Chesapeake Utilities
CPK
$3.31B
$23.4M 0.21%
194,324
-50,037
-20% -$5.92M
COLB icon
162
Columbia Banking Systems
COLB
$8.84B
$22.7M 0.2%
+589,390
New +$25M
FWRD icon
163
Forward Air
FWRD
$467M
$22.2M 0.2%
246,984
-9,293
-4% -$856K
LKFN icon
164
Lakeland Financial Corp
LKFN
$1.58B
$21.9M 0.19%
355,739
-11,820
-3% -$757K
JWN
165
DELISTED
Nordstrom
JWN
$21.8M 0.19%
595,994
-18,101
-3% -$661K
CHD icon
166
Church & Dwight Co
CHD
$23.7B
$19.6M 0.17%
229,885
+14,265
+7% +$1.23M
NTGR icon
167
NETGEAR
NTGR
$663M
$19.6M 0.17%
510,182
-19,667
-4% -$763K
EW icon
168
Edwards Lifesciences
EW
$48.2B
$19.5M 0.17%
188,509
-7,200
-4% -$679K
DLB icon
169
Dolby
DLB
$4.97B
$19.5M 0.17%
198,399
+10,973
+6% +$1.08M
SLB icon
170
SLB Ltd
SLB
$74.2B
$19.1M 0.17%
596,642
+9,249
+2% +$284K
JKHY icon
171
Jack Henry & Associates
JKHY
$11.2B
$18.7M 0.17%
114,228
+10,102
+10% +$1.61M
GDOT icon
172
Green Dot
GDOT
$758M
$18.5M 0.16%
394,936
+84,436
+27% +$3.76M
LW icon
173
Lamb Weston
LW
$7.51B
$17.9M 0.16%
221,307
+19,620
+10% +$1.57M
MNRO icon
174
Monro
MNRO
$537M
$17.7M 0.16%
278,479
-8,800
-3% -$582K
DHR icon
175
Danaher
DHR
$140B
$17.5M 0.16%
73,451
-1,201
-2% -$266K

Similar funds

Boston Trust Walden's Q2 2021 Portfolio in Review

As of Q2 2021, Boston Trust Walden held 393 positions worth $11.2B, up 8.9% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2021 filing shows 24 new, 178 increased, 115 reduced and 8 closed positions. Its largest new stake was Helen of Troy: 132,720 shares worth $30.3M. The largest sale was Cantel Medical Corporation, an estimated $52.2M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2021 buy was Helen of Troy: 132,720 shares worth $30.3M.
  • Boston Trust Walden added most to Chemed in Q2 2021, an estimated $33.2M increase.
  • Boston Trust Walden's biggest Q2 2021 reduction was Bruker, cutting an estimated $42.9M.
  • Boston Trust Walden fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $52.2M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $11.2B portfolio in Q2 2021.
  • Boston Trust Walden opened 24 new positions and closed 8 in Q2 2021.
  • Boston Trust Walden's portfolio value rose 8.9% quarter-over-quarter to $11.2B.

Based on Boston Trust Walden's 13F filing for Q2 2021, filed 22 Jul 2021.